Inhibitor of ghrelin receptor reverses gefitinib resistance in lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibitor of ghrelin receptor reverses gefitinib resistance in lung cancer

Published:2019-04-24 Issue:3 Volume:32 Page:360-366
ISSN:1749-0774
Container-title:Human Cell
language:en
Short-container-title:Human Cell

Author:

Li Xiaoyou,Zhao Xia,Li Chenchen,Liu Siwen,Yan Fei,Teng Yue,Feng Jifeng,Miao Dengshun

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology

Link

http://link.springer.com/content/pdf/10.1007/s13577-019-00245-5.pdf

Reference35 articles.

1. Carreras-Torres R, Johansson M, Haycock PC, et al. Obesity, metabolic factors and risk of different histological types of lung cancer: a Mendelian randomization study. Plos One. 2017;12:e0177875.

2. Román M, Baraibar I, López I, et al. KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Mol Cancer. 2018;17:33.

3. Blandin Knight S, Crosbie PA, Balata H, et al. Progress and prospects of early detection in lung cancer. Open Biol. 2017; 7:170070.

4. Cheng WQ, Zheng RS, Zhang SW, et al. Analysis of Chinese lung cancer incidence and death from 2003 to 2007. J Pract Oncol. 2012;26:6–10.

5. Zheng YW, Li RM, Zhang XW, Ren XB. Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome. Cancer Invest. 2013;31:197–205.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ghrelin attenuates inflammation in diabetic lung disease by TLR4 pathway in vivo and in vitro;BMJ Open Diabetes Research & Care;2023-04

2. Ghrelin and its role in gastrointestinal tract tumors (Review);Molecular Medicine Reports;2021-07-19

3. Medicinal herbs and bioactive compounds overcome the drug resistance to epidermal growth factor receptor inhibitors in non‑small cell lung cancer (Review);Oncology Letters;2021-07-08

4. TASP1 Promotes Proliferation and Migration in Gastric Cancer via EMT and AKT/P-AKT Pathway;Journal of Immunology Research;2021-04-29

5. Attribution of Ghrelin to Cancer; Attempts to Unravel an Apparent Controversy;Frontiers in Oncology;2019-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3